down arrow

Kopran

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE082A01010
  • NSEID: KOPRAN
  • BSEID: 524280
INR
189.10
14.65 (8.4%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 4.52 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

184.35192.55

52 Week

157.00369.20
Valuation
Technical
Day's Volume

CASH

4.52 lacs (178.23%) Volume

Shareholding (Dec 2024)

FII

0.86%

Held by 30 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

44.46%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor long term growth as Net Sales has grown by an annual rate of 11.59% and Operating profit at 12.53% over the last 5 years

 
2

Negative results in Dec 24

3

Stock is technically in a Mildly Bearish range

4

Falling Participation by Institutional Investors

5

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 913 Cr (Micro Cap)

stock-summary
P/E

18.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

1.72%

stock-summary
Debt Equity

0.23

stock-summary
Return on Equity

10.64%

stock-summary
Price to Book

1.69

Revenue and Profits (1 Year):
Net Sales:
166 Cr
(Quarterly Results - Dec 2024)
Net Profit:
10 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (1.72%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-35.46%
0%
-35.46%
1 Year
-31.84%
1.18%
-30.66%
2 Years
36.63%
4.24%
40.87%
3 Years
-41.19%
4.04%
-37.15%
4 Years
57.26%
5.39%
62.65%
5 Years
547.6%
43.40%
591.0%

Latest dividend: 3 per share ex-dividend date: Sep-02-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
11.59%
EBIT Growth (5y)
12.53%
EBIT to Interest (avg)
9.03
Debt to EBITDA (avg)
1.32
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.19
Tax Ratio
25.11%
Dividend Payout Ratio
28.38%
Pledged Shares
0
Institutional Holding
0.87%
ROCE (avg)
14.17%
ROE (avg)
13.89%
Valuation key factors
Factor
Value
P/E Ratio
18
Industry P/E
33
Price to Book Value
1.69
EV to EBIT
16.21
EV to EBITDA
12.88
EV to Capital Employed
1.56
EV to Sales
1.49
PEG Ratio
1.01
Dividend Yield
1.72%
ROCE (Latest)
10.37%
ROE (Latest)
10.64%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 5 Schemes (0.0%)

FIIs

Held by 30 FIIs (0.86%)

Promoter with highest holding

Oricon Enterprises Ltd (12.89%)

Highest Public shareholder

Viraj Russell Mehta (1.85%)

Individual Investors Holdings

41.35%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 4.61% vs 0.58% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is -34.14% vs 127.19% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "166.24",
          "val2": "158.92",
          "chgp": "4.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "19.84",
          "val2": "23.59",
          "chgp": "-15.90%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.16",
          "val2": "2.24",
          "chgp": "-3.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "10.40",
          "val2": "15.79",
          "chgp": "-34.14%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.93%",
          "val2": "14.84%",
          "chgp": "-2.91%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 7.94% vs 11.13% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 11.73% vs 35.02% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "291.00",
          "val2": "269.59",
          "chgp": "7.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "32.90",
          "val2": "29.14",
          "chgp": "12.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.42",
          "val2": "3.77",
          "chgp": "17.24%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "18.48",
          "val2": "16.54",
          "chgp": "11.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.31%",
          "val2": "10.81%",
          "chgp": "0.50%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 6.70% vs 6.97% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -10.67% vs 68.39% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "457.24",
          "val2": "428.51",
          "chgp": "6.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "52.74",
          "val2": "52.73",
          "chgp": "0.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "6.58",
          "val2": "6.01",
          "chgp": "9.48%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "28.88",
          "val2": "32.33",
          "chgp": "-10.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.53%",
          "val2": "12.31%",
          "chgp": "-0.78%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 11.54% vs 15.39% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 87.15% vs -55.38% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "614.59",
          "val2": "550.99",
          "chgp": "11.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "74.41",
          "val2": "51.80",
          "chgp": "43.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "8.59",
          "val2": "6.08",
          "chgp": "41.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "50.96",
          "val2": "27.23",
          "chgp": "87.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.11%",
          "val2": "9.40%",
          "chgp": "2.71%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
166.24
158.92
4.61%
Operating Profit (PBDIT) excl Other Income
19.84
23.59
-15.90%
Interest
2.16
2.24
-3.57%
Exceptional Items
0.00
0.00
Consolidate Net Profit
10.40
15.79
-34.14%
Operating Profit Margin (Excl OI)
11.93%
14.84%
-2.91%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 4.61% vs 0.58% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2024 is -34.14% vs 127.19% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
291.00
269.59
7.94%
Operating Profit (PBDIT) excl Other Income
32.90
29.14
12.90%
Interest
4.42
3.77
17.24%
Exceptional Items
0.00
0.00
Consolidate Net Profit
18.48
16.54
11.73%
Operating Profit Margin (Excl OI)
11.31%
10.81%
0.50%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 7.94% vs 11.13% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 11.73% vs 35.02% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
457.24
428.51
6.70%
Operating Profit (PBDIT) excl Other Income
52.74
52.73
0.02%
Interest
6.58
6.01
9.48%
Exceptional Items
0.00
0.00
Consolidate Net Profit
28.88
32.33
-10.67%
Operating Profit Margin (Excl OI)
11.53%
12.31%
-0.78%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 6.70% vs 6.97% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is -10.67% vs 68.39% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
614.59
550.99
11.54%
Operating Profit (PBDIT) excl Other Income
74.41
51.80
43.65%
Interest
8.59
6.08
41.28%
Exceptional Items
0.00
0.00
Consolidate Net Profit
50.96
27.23
87.15%
Operating Profit Margin (Excl OI)
12.11%
9.40%
2.71%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 11.54% vs 15.39% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 87.15% vs -55.38% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Kopran Ltd stock-summary
stock-summary
Kopran Ltd
Micro Cap
Pharmaceuticals & Drugs
Kopran Ltd., incorporated on April 26, 1958, was promoted by the Somani group and is controlled by Parijat Enterprises. The company came out with a public issue at a premium, in Nov.'92, to finance its backward integration project to produce drug intermediates for semi-synthetic drugs, and also to expand its antibiotic facility. Kopran manufactures pharmaceutical finished dosage forms and bulk drugs and distributes electronic equipment.
Company Coordinates stock-summary
Company Details
Parijat House 1076, Dr E Moses Road Worli Mumbai Maharashtra : 400018
stock-summary
Tel: 91-22-43661111
stock-summary
http://www.kopran.com
stock-summary
investors@kopran.com
Registrar Details
Bigshare Services Pvt Ltd , E-2 , Ansa Industrial Estate, Saki Vihar Road, Saki Naka, Andheri (E), Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."